New Chapter

Zyflamend Prostate

F
N+ Score58
Longevity & NAD+Serving: 2 Capsule(s)Type: Other Combinations [A1325]

New Chapter Zyflamend Prostate is a dietary supplement formulated with a blend of herbs including Saw Palmetto, Green Tea, and Selenium. This product is designed to support prostate health with 2 capsules per serving. It combines traditional botanicals in a comprehensive formula.

About This Product

Zyflamend Prostate by New Chapter is a longevity & nad+ supplement containing 14 active ingredients. It has earned an N+ Score of 58/100 (Grade F).

Notable clinical-dose ingredients include Selenium.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +1 ingredient(s) at clinical dose levels
  • +Rich formula with 14 active ingredients

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (14 ingredients)

IngredientAmountDose Adequacy
Selenium50.000 mcgAdequate
Ginger80.000 mgN/A
organic Pumpkin seed oil90.000 mgN/A
Turmeric62.500 mgN/A
Holy Basil hydroethanolic extract50.000 mgN/A
Chinese Skullcap aqueous extract100.000 mgN/A
Saw Palmetto supercritical extract320.000 mgN/A
organic Green Tea aqueous extract100.000 mgN/A
Rosemary75.000 mgN/A
Nettle hydroethanolic extract75.000 mgN/A
Hu Zhang hydroethanolic extract40.000 mgN/A
Chinese Goldthread aqueous extract20.000 mgN/A
Barberry hydroethanolic extract20.000 mgN/A
organic Oregano supercritical extract20.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.